Neuroscience Research Methods 3 Flashcards
In neuropharmacology, what is meant by affinity? (1)
How tightly a drug binds to its target
Give three research techniques which could be used to assess a drug’s affinity. (3)
- Radioligand binding
- Fluorescent ligand binding
- Fluorescent/bioluminescent Resonance Energy Transfer (FRET/BRET)
Briefly describe how radioligand binding studies would be caried out. (4)
- Cells/membranes/homogenated tissue incubated with radiolabelled ligand
- During incubation ligand binds to target
- Then either centrifuge (bound ligand forms pellet) or filter (bound ligand trapped in filter) to separate tissue+ligand from unbound ligand
- Measure radioactivity
When using radioligand or fluorescent ligand binding studies to test drug affinity, describe a method which could be used to differentiate between specific binding and non-specific binding. (4)
- Add labelled ligand to sample and allow it to bind (as normal)
- Then add another unlabelled ligand for same target
- Unlabelled ligand will displace specific binding but will leave non-specific binding
- So any signal left over will be from non-specific binding
Give two ways to perform radioligand/fluorescent ligand binding studies. (2)
ie. will produce two different sets of results
- Saturation binding
- Competition binding
Describe how you would produce a dose-response curve based on radioligand/fluorescent ligand saturation binding studies. (1)
Vary concentration of ligand and measure response
What is the meaning of Bmax, when applied to radioligand/fluorescent ligand saturation binding studies. (1)
What can you infer from Bmax? (1)
Bmax = maximum specific binding
Can infer the total number of binding sites in tissue sample.
What is the meaning of KD, when applied to radioligand/fluorescent ligand saturation binding studies. (2)
How would a KD value be interpreted? (1)
KD = equilibrium dissociation constant
Concentration that occupies 50% binding sites
Higher KD = lower affinity
Give a disadvantage of using saturation binding as opposed to competition binding when performing a radioligand binding study. (1)
Can only be used if the drug of interest has a radioactive form.
Describe how you would produce a dose-response curve based on radioligand/fluorescent ligand competition binding studies. (3)
- Add a radioligand to the target and allow to bind
- Add varying concentrations of ligand of interest, which is non-labelled
- Ligand of interest will compete for binding sites and displace radioligand
What is the meaning of IC50, when applied to radioligand/fluorescent ligand competition binding studies. (1)
How would IC50 results be interpreted? (1)
IC50 = concentration which causes 50% displacement
Higher IC50 = lower affinity
In what circumstances might it be more beneficial to use competition binding when performing a radioligand / fluorescent ligand binding experiment. (1)
Can be used to test a new/rare drug which doesn’t have a radiolabelled form.
Give two advantages of performing radioligand binding studies as opposed to fluorescent ligand binding studies. (2)
- Radiolabel is stable and not light sensitive
- Small size of radiolabel shouldn’t interfere with binding
Give three disadvantages of performing radioligand binding studies as opposed to fluorescent ligand binding studies. (3)
- Safety and practicality issues of radioligands
- Need high quantity of tissue (can’t study single cells)
- Can only measure a single time point (if you want to measure a response over time you have to perform separate assays for each time point)
Right now, go to neuropharmacology notes, and look at table under radioligand binding.
Answer the questions.
I hope you did this and didn’t skip this card.
Briefly describe how fluorescent ligand binding studies are carried out. (4)
- Cells/membranes/homogenated tissue incubated with fluorescently labelled ligand
- During incubation ligand binds to target
- Then either centrifuge (bound ligand forms pellet) or filter (bound ligand trapped in filter) to separate tissue+ligand from unbound ligand
- Measure fluorescence
Give two advantages of performing fluorescent ligand binding studies as opposed to radioligand binding studies. (2)
- Fewer safety / practicality concerns than radioactive
- More versatile detection options (eg. can view structure with fluorescent microscopy)
Give two disadvantages of performing fluorescent ligand binding studies as opposed to radioligand binding studies. (2)
- Light sensitive specimens
- Fluorophores used are large - can influence ligand binding
Complete the sentence relating to fluorescent/bioluminescent resonance energy transfer (FRET/BRET) affinity studies. (1)
FRET/BRET are both techniques based on ……………………………..
Hint: answer is a phrase
energy transfer between paired dyes on a receptor and a ligand
Briefly describe the principle behind the FRET/BRET technique. (2)
How can this imply affinity? (1)
When in close proximity, the donor dye (eg. on a ligand) transfers energy to an acceptor dye (eg. on a receptor) and alters the emitted wavelength.
*BRET is the same but a donor light-emitting enzyme produces a photon, then transfers energy to an acceptor rather than a dye
This implies affinity because the energy transfer will only take place if the ligand and target are in very close contact (ie. they are bound to each other).
What is the difference between FRET and BRET? (2)
FRET uses fluorescent dyes
whereas BRET uses light-emitting enzymes
Give three advantages of FRET/BRET techniques. (3)
- High sensitivity
- High throughput (many tests can be done at once)
- Kinetic (time course) assays possible (as signals can be recorded without disrupting cells)
In neuropharmacology research, what is meant by the term ‘efficacy’? (1)
How effective a drug is at activating its target
Define the term ‘agonist’. (1)
Binds to a receptor and activates it
Define the term ‘antagonist’. (2)
Binds to a receptor without activating it
and prevents the effect of an agonist.
Define the term ‘partial agonist’. (3)
Binds to a receptor
but only partially activates it
so reduces the effect of the full agonist.
Define the term ‘inverse agonist’. (1)
Binds to receptor and reduces existing activity.
Describe the effect on a dose-response curve of adding a reversible, competitive antagonist. (1)
Parallel right shift - antagonist can be overcome by increasing agonist concentration.
Describe the effect on a dose-response curve of adding a non-competitive or an irreversible antagonist. (1)
Reduced maximum response
Give three possible research techniques that could be used in efficacy studies. (3)
- ‘Classical’ efficacy assays
- Fluorescent/bioluminescent resonance energy transfer (FRET/BRET)
- Uptake/release assays
Which of the three common techniques used to study efficacy are used for receptors, and which are used for transporters? (2)
RECEPTORS:
- Classical efficacy assays
- FRET/BRET
TRANSPORTERS:
- Uptake/release assay
Describe how classical efficacy assays can be used to measure drug efficacy. (2)
Measure downstream production of intracellular signalling messengers
eg. cAMP, IP3, reporter genes
Complete the sentence relating to fluorescent/bioluminescent resonance energy transfer (FRET/BRET) efficacy studies. (1)
FRET/BRET are both techniques based on ……………………………..
Hint: answer is a phrase
energy transfer between paired dyes on different parts of the same receptor.
Briefly describe how FRET/BRET techniques can be used to determine drug efficacy. (3)
- Receptor activation causes conformational change
- Proximity of donor and acceptor dyes changes
- Emitted wavelength of dye is altered
Give three advantages and two disadvantages of FRET/BRET studies for efficacy. (5)
ADVANTAGES:
- High sensitivity
- High throughput
- Can get time-course assays
DISADVANTAGES:
- Interference from autofluorescence
- Photobleaching (light sensitive)
Describe how to perform an uptake assay to
test efficacy of a ligand binding to a transporter. (3)
- Incubate cells expressing target transporter, test ligand, and radiolabelled/fluorescent substrate for the transporter
- During incubation, substrate either taken up by transporter or not depending on test ligand
- Wash sample to remove extracellular substrate, and measure radioactivity/fluorescence in cells
Describe how to perform a release assay to
test efficacy of a ligand binding to a transporter. (4)
- Pre-incubate cells expressing target transporter and radiolabelled substrate for transporter, and cells will take up substrate
- Wash to remove extracellular substrate
- Incubate with test ligand
- Collect samples of extracellular fluid to measure release of radioactive substrate
When performing uptake and release assays to test efficacy, describe the effect of MDMA on uptake and release of 5-HT and dopamine. (4)
- Inhibits uptake of DA
- But inhibits uptake of 5-HT more
- Increases release of DA
- Increases release of 5-HT to same extent
When performing uptake and release assays to test efficacy, describe the effect of methamphetamine on uptake and release of 5-HT and dopamine. (4)
- Inhibits uptake of DA
- Inhibits uptake of 5-HT (but not as much as dopamine)
- Increases release of DA
- Increases release of 5-HT (but not as much as dopamine)
Describe how affinity of an antipsychotic for the D2 receptor affects what dose will be required for a therapeutic effect. (1)
Lower affinity = higher dose needed
Describe what is meant by ‘biological response’ in neuropharmacology. (1)
The physical/therapeutic consequences of drug activity.
Give five potential things that can be looked at to assess the biological response of a drug. (5)
- Transcriptomics
- Cell morphology
- Calcium signalling
- Electrophysiology
- Immunocytochemistry
Describe three uses of human induced pluripotent stem cells in assessing the biological response of a drug. (3)
- Measure biological responses
- Understand disease mechanisms
- Test drug efficacy in groups of patients (ultimate goal is personalised medicine)
(Can test drugs on neurones/cells which have specific genetic mutations or cells from specific patients to see whether they have the desired response)
Give one advantage and two disadvantages of using humans iPSCs to assess the biological responses of drugs. (3)
ADVANTAGE:
- Can be used to study genetic contributions to a disease
DISADVANTAGES:
- Little insight into environmental contributions
- Cells remain immature so little insight into effects of ageing
Give three reasons why animal studies are essential to neuroscience research. (3)
- Ethics of going straight to humans
- Allows tighter control of variables than in humans
- Can give mechanistic insight
Give four advantages and one disadvantage of using animal studies to research neuroscience and neurological illnesses. (5)
ADVANTAGES:
- Similar neuroanatomy to humans
- Same neurotransmitters as humans
- High receptor homology with humans
- Rodents and humans share core behaviours related to feeding, pain, etc
DISADVANTAGE:
- Rodents don’t develop complex mental illnesses (but may be able to show some aspects such as cognitive and affective changes)
Define what is meant by ‘behavioural test’. (1)
Observing an animal and measuring an outcome
Name three types of validity that can be applied when producing animal models. (3)
- Face validity
- Construct validity
- Predictive validity
Describe ‘face validity’, as applied to animal models. (1)
Changes in the model resemble those in the disease.
eg. behavioural changes seen mimic aspects of the symptoms
Describe ‘construct validity’, as applied to animal models. (1)
Mechanism used to induce the model reflects known cause of the disease.
eg. genetic basis for genetic disorder
Describe ‘predictive validity’, as applied to animal models. (1)
Drug effects in model predict those in the disease
ie. true positives and negatives without false positives and negatives
Give three ways that behavioural tests alone (not paired with an animal model) can be used in neuroscience research. (3)
- Investigate basic biology (eg. effect of age/sex on behaviour)
- Target validation (eg. looking at role of a molecule in specific behaviour)
- Mechanistic insight (eg. neuroanatomical substrates of behaviour; what area of brain causes specific behaviours)
Give three ways that combining animal models with behavioural testing can be used in neuroscience research. (3)
- Give new insight into disease mechanisms (eg. risk exposure)
- Test new therapeutics for symptom management and prevention
- Move towards patient stratification for personalised medicine (eg. induce same faulty gene in animal as seen in patient and see which drug works best)
Suggest three behavioural tests which could be used to assess anxiety. (3)
Describe generally how these tests might be able to indicate anxiety in a rodent. (1)
- Open field
- Elevated plus maze
- Light-dark box
Measure a rodent’s innate desire to explore a novel environment vs evolutionary avoidance of bright/open spaces.
Briefly describe how a rodent open field test would be performed and how the results would be interpreted. (4)
- Animal placed into open area
- Tracked for locomotor activity and time in peripheral and central zones
- Increased time in periphery = more anxiety
- Increased time in centre = less anxiety
Briefly describe how a rodent elevated plus maze test would be performed and how the results would be interpreted. (4)
- Animal placed on elevated maze with open and closed arms
- Tracked for locomotor activity and time in open and closed arms
- More time in closed arms = more anxiety
- More time in open arms = less anxiety